Over a month ago
Conference/Events
Vehicle Technology &…
Vehicle Technology & Mobility Virtual Conference 2021 will be held on March 9-10.
Show Hide Related Items >> <<
03/08/21 XL Fleet refutes 'inaccurate and misinformed' report by short-seller 03/04/21 XL Fleet responds to recent short seller report, says conclusions 'flawed' 03/03/21 Muddy Waters short XL Fleet, doubts it will be serious player in electrification 03/03/21 XL Fleet down 16% after Muddy Waters publishes short report 01/26/21 Veoneer, Qualcomm to collaborate on scalable ADAS/AD solutions 01/20/21 Veoneer rises 8.8% 01/20/21 Veoneer rises 7.7% 01/07/21 Veoneer sees FY20 total order book value $14B 03/08/21 Velodyne Lidar announces executive appointments 02/22/21 Velodyne Lidar appoints Dr. Joseph Culkin chairman effective immediately 02/19/21 Luminar, Velodyne Lidar move up after Bloomberg says Apple looking at LiDAR 02/10/21 Velodyne Lidar signs five-year sales agreement with ThorDrive 02/18/21 Gentherm postpones Q4, FY20 earnings release 01/11/21 Gentherm appoints Betsy Meter to board of directors 01/04/21 Gentherm appoints Steve Fletcher as SVP, GM of Medical 10/29/20 Gentherm to delay Q3 conference call 01/28/21 Littelfuse acquires Hartland Controls, terms not disclosed 11/10/20 Littelfuse director Nathan Zommer sells almost $1.8M in company shares 11/01/20 Fly Intel: Top five weekend stock stories 02/19/21 Insmed says TPIP 'generally safe and well tolerated' in Phase 1 study 01/04/21 Insmed initiates frontline clinical trial program for ARIKAYCE 12/02/20 Insmed initiates Phase 3 study of Brensocatib in patients with bronchiectasis 11/13/20 Insmed's Brensocatib receives EMA priority medicines designation for NCFBE 02/16/21 Arcimoto Fuv qualifies for the $1,500 California Clean Fuel Reward 01/25/21 Arcimoto reports delivery of 97 Arcimotos to customers in 2020, up 110% 01/25/21 Arcimoto to acquire Tilting Motor Works 01/12/21 Arcimoto joins Zero Emission Transportation Association 02/15/21 BorgWarner acquires German battery maker Akasol for EUR 754M 10/22/20 BorgWarner collaborating with Michigan university on connected vehicle project 10/07/20 Simpson Manufacturing to replace Delphi Technologies in S&P 400 at open on 10/7 10/02/20 BorgWarner-backed Romeo said in talks to come public via SPAC deal 02/22/21 Credit Suisse United Therapeutics price target raised to $196 from $169 at Credit Suisse 01/19/21 Credit Suisse Insmed price target raised to $60 from $50 at Credit Suisse 12/17/20 Berenberg Insmed initiated with a Buy at Berenberg 11/23/20 Evercore ISI Insmed resumed with an Outperform at Evercore ISI 03/09/21 Vertical Group Himax reinstated with a Neutral at Vertical Group 02/08/21 Northland Himax price target raised to $13 from $4.50 at Northland 01/27/21 Nomura Himax upgraded to Buy from Neutral at Nomura 11/30/20 Baird Himax price target raised to $11 from $8 at Baird 03/02/21 Roth Capital Gentherm price target raised to $85 from $53 at Roth Capital 01/22/21 JPMorgan Gentherm downgraded to Underweight on valuation at JPMorgan 01/22/21 JPMorgan Gentherm downgraded to Underweight from Neutral at JPMorgan 12/23/20 Barrington Gentherm double downgraded to Underperform at Barrington following rally 01/25/21 Roth Capital Roth not expecting major reaction in stock following Arcimoto Q4 deliveries miss 08/20/20 Roth Capital Arcimoto downgraded to Neutral from Buy at Roth Capital 08/20/20 H.C. Wainwright Arcimoto price target raised to $10 from $7 at H.C. Wainwright 06/25/20 Aegis Arcimoto initiated with a Buy at Aegis 02/23/21 Cleveland Research BorgWarner assumed with a Neutral at Cleveland Research 01/21/21 Barclays BorgWarner price target raised to $41 from $39 at Barclays 01/20/21 Deutsche Bank BorgWarner named 'Catalyst Call: Buy Idea' at Deutsche Bank 11/12/20 Wolfe Research BorgWarner downgraded to Peer Perform from Outperform at Wolfe Research 02/09/21 Craig-Hallum Velodyne target cut to $29 at Craig-Hallum as 'lower visibility' reasons emerge 02/04/21 Veoneer price target raised to $25 from $20 at Deutsche Bank 02/04/21 Mizuho Veoneer price target raised to $32 from $23 at Mizuho 02/04/21 Veoneer price target raised to $28 from $25 at Barclays 01/14/21 Fly Intel: Top five analyst initiations 01/14/21 Benchmark Benchmark starts 'first mover' Velodyne Lidar at Buy with $32 price target 01/14/21 Benchmark Velodyne Lidar initiated with a Buy at Benchmark 01/29/21 Canaccord Canaccord sees XL Fleet going to $30 per share on 'first-mover' advantage 01/29/21 Canaccord XL Fleet initiated with a Buy at Canaccord 01/22/21 Fly Intel: Top five analyst initiations 01/22/21 BTIG XL Fleet initiated with a Buy at BTIG 10/19/20 Baird Littelfuse reinstated with an Outperform at Baird 06/25/20 Longbow Longbow cuts second half estimates for semis and components 05/18/20 Baird Littelfuse Q2 at trough demand levels, says Baird 04/20/20 Loop Capital Littelfuse initiated with a Hold at Loop Capital 02/03/21 Veoneer reports Q4 EPS (82c), consensus (86c) 02/25/21 Velodyne Lidar reports Q4 EPS (12c), consensus (11c) 01/07/21 Velodyne Lidar sees Q4 revenue $15.5M-$16M, consensus $29.55M 03/01/21 Gentherm sees FY21 product revenue $1.05B-$1.13B, consensus $1.02B 03/01/21 Gentherm reports Q4 adjusted EPS $1.16, consensus 71c 02/18/21 Gentherm sees 2021 product revenue $1.05B-$1.13B, consensus $1B 02/18/21 Gentherm reports 2020 revenue $940M, consensus $873.7M 02/03/21 Littelfuse sees Q1 adjusted EPS $1.76-$1.92, consensus $1.72 02/03/21 Littelfuse reports Q4 adjusted EPS $2.22, consensus $1.56 10/28/20 Littelfuse sees Q4 revenue growth 7%-10%, consensus $336.03M 10/28/20 Littelfuse reports Q3 adjusted EPS $2.16, consensus $1.14 02/25/21 Insmed reports Q4 EPS ($1.00), consensus (70c) 10/29/20 Insmed reports Q3 GAAP EPS (63c), consensus (61c) 02/04/21 Himax sees Q1 non-IFRS EPS 30.1c-34.1c, may not compare to consensus 9c 02/04/21 Himax reports Q4 non-IFRS EPS 19.7c, consensus 17c 01/07/21 Himax reports preliminary Q4 adjusted EPS 19.7c, consensus 15c 11/12/20 Himax reports Q3 non-IFRS EPS 7.3c, consensus 3c 11/16/20 Arcimoto reports Q3 EPS (15c), consensus (13c) 02/11/21 BorgWarner sees 2021 adjusted EPS $3.85-$4.25, consensus $3.84 02/11/21 BorgWarner reports Q4 adjusted EPS $1.18, consensus 93c 02/10/21 Notable companies reporting before tomorrow's open
Recommendations
Roth Capital analyst Matt…
Roth Capital analyst Matt Koranda raised the firm's price target on Gentherm to $85 from $53 and keeps a Buy rating on the shares. Gentherm's Q4 results were strong, with roughly 20pts of excess growth vs. the industry, while also continuing to outperform margin expectations, Koranda tells investors in a research note. The analyst believes the bookings environment looks highly-attractive for Gentherm, and sees a potential ClimateSense commercial booking on the horizon, which would be transformative for the business in the next cycle.
Show Hide Related Items >> <<
02/18/21 Gentherm postpones Q4, FY20 earnings release 01/11/21 Gentherm appoints Betsy Meter to board of directors 01/04/21 Gentherm appoints Steve Fletcher as SVP, GM of Medical 10/29/20 Gentherm to delay Q3 conference call 01/22/21 JPMorgan Gentherm downgraded to Underweight on valuation at JPMorgan 01/22/21 JPMorgan Gentherm downgraded to Underweight from Neutral at JPMorgan 12/23/20 Barrington Gentherm double downgraded to Underperform at Barrington following rally 12/23/20 Barrington Gentherm downgraded to Underperform from Outperform at Barrington 03/01/21 Gentherm sees FY21 product revenue $1.05B-$1.13B, consensus $1.02B 03/01/21 Gentherm reports Q4 adjusted EPS $1.16, consensus 71c 02/18/21 Gentherm sees 2021 product revenue $1.05B-$1.13B, consensus $1B 02/18/21 Gentherm reports 2020 revenue $940M, consensus $873.7M
Earnings
Sees FY21 adjusted EBITDA…
Sees FY21 adjusted EBITDA between 17%-9% of product revenues;Full-year effective tax rate between 22%-24%; Capital expenditures between $50M-$60M.
Show Hide Related Items >> <<
02/18/21 Gentherm postpones Q4, FY20 earnings release 01/11/21 Gentherm appoints Betsy Meter to board of directors 01/04/21 Gentherm appoints Steve Fletcher as SVP, GM of Medical 10/29/20 Gentherm to delay Q3 conference call 01/22/21 JPMorgan Gentherm downgraded to Underweight on valuation at JPMorgan 01/22/21 JPMorgan Gentherm downgraded to Underweight from Neutral at JPMorgan 12/23/20 Barrington Gentherm double downgraded to Underperform at Barrington following rally 12/23/20 Barrington Gentherm downgraded to Underperform from Outperform at Barrington 03/01/21 Gentherm reports Q4 adjusted EPS $1.16, consensus 71c 02/18/21 Gentherm sees 2021 product revenue $1.05B-$1.13B, consensus $1B 02/18/21 Gentherm reports 2020 revenue $940M, consensus $873.7M 02/18/21 Gentherm reports Q4 products revenue $288.9M, consensus $249.51M
Earnings
Reports Q4 revenue…
Reports Q4 revenue $288.9M, consensus $257.29M.
Show Hide Related Items >> <<
02/18/21 Gentherm postpones Q4, FY20 earnings release 01/11/21 Gentherm appoints Betsy Meter to board of directors 01/04/21 Gentherm appoints Steve Fletcher as SVP, GM of Medical 10/29/20 Gentherm to delay Q3 conference call 01/22/21 JPMorgan Gentherm downgraded to Underweight on valuation at JPMorgan 01/22/21 JPMorgan Gentherm downgraded to Underweight from Neutral at JPMorgan 12/23/20 Barrington Gentherm double downgraded to Underperform at Barrington following rally 12/23/20 Barrington Gentherm downgraded to Underperform from Outperform at Barrington 02/18/21 Gentherm sees 2021 product revenue $1.05B-$1.13B, consensus $1B 02/18/21 Gentherm reports 2020 revenue $940M, consensus $873.7M 02/18/21 Gentherm reports Q4 products revenue $288.9M, consensus $249.51M 10/29/20 Gentherm sees Q4 product revenues $240M-$260M, consensus $228.41M
Earnings
Sees Adjusted EBITDA…
Sees Adjusted EBITDA between 17% and 19% of product revenues
Show Hide Related Items >> <<
02/18/21 Gentherm postpones Q4, FY20 earnings release 01/11/21 Gentherm appoints Betsy Meter to board of directors 01/04/21 Gentherm appoints Steve Fletcher as SVP, GM of Medical 10/29/20 Gentherm to delay Q3 conference call 01/22/21 JPMorgan Gentherm downgraded to Underweight on valuation at JPMorgan 01/22/21 JPMorgan Gentherm downgraded to Underweight from Neutral at JPMorgan 12/23/20 Barrington Gentherm double downgraded to Underperform at Barrington following rally 12/23/20 Barrington Gentherm downgraded to Underperform from Outperform at Barrington 02/18/21 Gentherm reports 2020 revenue $940M, consensus $873.7M 02/18/21 Gentherm reports Q4 products revenue $288.9M, consensus $249.51M 10/29/20 Gentherm sees Q4 product revenues $240M-$260M, consensus $228.41M 10/29/20 Gentherm reports Q3 adjusted EPS 91c, consensus 49c